Dosing guidance for intravenous colistin in critically-ill patients.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background.: Intravenous colistin is difficult to use because plasma concentrations for antibacterial effect overlap those causing nephrotoxicity, and there is large interpatient variability in pharmacokinetics. The aim was to develop dosing algorithms for achievement of a clinically desirable average steady-state plasma colistin concentration (Css,avg) of 2 mg/L. Methods.: Plasma concentration-time data from 214 adult critically ill patients (creatinine clearance, 0–236 mL/min; 29 receiving renal replacement therapy [RRT]) were subjected to population pharmacokinetic analysis. Development of an algorithm for patients not receiving RRT was based on the relationship between the dose of colistimethate that would be needed to achieve a desired Css,avg and creatinine clearance. The increase in colistin clearance when patients were receiving RRT was determined from the population analysis and guided the supplemental dosing needed. To balance potential antibacterial benefit against risk of nephrotoxicity the algorithms were designed to achieve target attainment rates of >80% for Css,avg ≥2 and <30% for Css,avg ≥4 mg/L. Results.: When algorithm doses were applied back to individual patients not receiving RRT (including those prescribed intermittent dialysis on a nondialysis day), >80% of patients with creatinine clearance <80 mL/min achieved Css,avg ≥2 mg/L, but for patients with creatinine clearance ≥80 mL/min, the target attainment was <40%, even with the maximum allowed daily dose of 360 mg colistin base activity. For patients receiving RRT, target attainment rates were >80% with the proposed supplemental dosing. In all categories of patients, <30% of patients attained Css,avg ≥4 mg/L. Conclusions.: The project has generated clinician-friendly dosing algorithms and pointed to circumstances in which intravenous monotherapy may be inadequate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Self-citationGaronzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Self-citationSandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Self-citationColistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
Self-citationPogue, J. M., Lee, J., Marchaim, D., Yee, V., Zhao, J. J., Chopra, T., Lephart, P., & Kaye, K. S. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir611 · Cited by 327
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Nation, R. L., Velkov, T., & Li, J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu213 · Cited by 310
Self-citationSorlí, L., Luque, S., Grau, S., Berenguer, N., Segura, C., Montero, M. M., Álvarez-Lerma, F., Knobel, H., Benito, N., & Horcajada, J. P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-380 · Cited by 225
Cheah, S.-E., Wang, J., Nguyen, V. T. T., Turnidge, J. D., Li, J., & Nation, R. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv267 · Cited by 206
Self-citationUpdated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Nation, R. L., Garonzik, S. M., Li, J., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Paterson, D. L., Turnidge, J. D., Forrest, A., & Silveira, F. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ964 · Cited by 168
Self-citation
Research works printed but not linked: 2
- Forrest, Toxicodynamics for colistin-associated changes in creatinine clearance. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 5–9 September 2014
- European Medicines Agency, Annex III: amendments to relevant sections of the summary of product characteristics and the package leaflets
Cited by
Items 201–273 of 273
Yeoh, D. K., Boast, A., Wen, S. C.-H., Williams, P. C. M., VOSS, L. M., Ritchie, B. K., Mostaghim, M., Lutui, F., Lei, A., Lai, T., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101735 · Cited by 3
Reviving Old Antibiotics: New Indications and Therapeutic Perspectives—A Review
Radkowski, P., Oszytko, J., Sobolewski, K., Trachte, F., Czerwińska-Rogowska, M., Onichimowski, D., & Majewska, M. (2026) · Pharmaceuticals · doi:10.3390/ph19020278 · Cited by 3
Leng, X., Xia, L., Zhou, H. H., Cheng, C.-H., Cui, C., Xia, J., & Xu, F. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102903 · Cited by 3
Lin, Y., Chen, K., Wang, J., Velkov, T., Zhou, Q. T., & Li, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02527-17 · Cited by 3
Self-citationHang, N. T. T., Venter, H., Woolford, L., Young, K. A., McCluskey, A., Garg, S., Page, S. W., Trott, D. J., & Ogunniyi, A. D. (2022) · Antibiotics · doi:10.3390/antibiotics11010065 · Cited by 3
Prestwood, J., Chang, D., McGann, P., & Barsoumian, A. E. (2018) · Military Medicine · doi:10.1093/milmed/usy241 · Cited by 3
Singhal, L., Singh, C., & Gautam, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00199-7 · Cited by 3
Nation, R. L., Merali, S. J., Thamlikitkul, V., Giamarellos‐Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix390 · Cited by 3
Self-citationRodjun, V., Montakantikul, P., Houngsaitong, J., Jitaree, K., & Nosoongnoen, W. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1275909 · Cited by 2
Li, P., Li, S., Zhang, J., Zeng, S., Li, Z., Xie, J., & Yang, Y. M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1625595 · Cited by 2
OBEZ HASTALARDA ANTİMİKROBİYAL İLAÇ DOZLARI
Bahap, M., Ekinci, P. B., Bayraktar‐Ekincioglu, A., & Demirkan, K. (2019) · STED / Sürekli Tıp Eğitimi Dergisi · doi:10.17942/sted.598625 · Cited by 3
Klyasova, G. A. (2020) · Oncohematology · doi:10.17650/1818-8346-2020-15-2-92-107 · Cited by 2
Giacobbe, D. R., Mirabella, M., Rinaldi, M., Losito, A. R., Raffaelli, F., Puente, F. D., Saffioti, C., Mikulska, M., Giannella, M., Viale, P., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10121554 · Cited by 2
Li, M., Azad, M. A. K., Ahmed, M. U., Zhu, Y., Song, J., Zhou, F., Chan, H., Velkov, T., Zhou, Q. T., & Li, J. (2022) · Antibiotics · doi:10.3390/antibiotics11030307 · Cited by 2
Self-citationTherapeutic Drug monitoring of colistin in critically ill patients: A narrative review
Ghoneim, R. H. (2023) · Saudi Journal of Clinical Pharmacy · doi:10.4103/sjcp.sjcp_33_23 · Cited by 2
Nazer, L. H., & Lê, J. (2019) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-019-00783-w · Cited by 2
Re-emerging Antibiotic- A Systematic Review on Colistin
Vellingiri, S., Nirojini, P. S., Pushpanathan, N., Raju, N., Palanivel, M., & Chinraj, V. D. (2022) · Indian Journal of Pharmacy Practice · doi:10.5530/ijopp.15.3.31 · Cited by 2
Viel, A. (2017) · theses.fr (ABES) · doi:10.70675/ad7235a1z0952z43f8zb9fczaab231dc4693 · Cited by 4
Suya, S., Nasomsong, W., Santimaleeworagun, W., Juntanawiwat, P., Chatreewonanakul, T., & Saelim, W. (2024) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2024.10.263 · Cited by 1
Suk, P., Rychlíčková, J., Součková, L., Kubíčková, V., Šíma, M., Šitina, M., Urbánek, K., & Šrámek, V. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107582 · Cited by 1
Meng, J., Yu, R., Wen, Z., Chen, S., Xie, X., Zhang, L., Sun, P., & Cao, X. (2025) · One Health Advances · doi:10.1186/s44280-025-00082-2 · Cited by 1
Colistin use and outcomes in Kuwait public hospitals
Alghanem, S. S., Alfouzan, W. A., Soliman, M. M., AlRoomi, E., Alajmi, S., Mahmoud, T. S. H., & Yagan, J. A. (2026) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2026.1808461 · Cited by 1
Pogue, J. M., Rybak, M. J., Abdul‐Mutakabbir, J. C., Stamper, K. C., Marchaim, D., Thamlikitkul, V., Carmeli, Y., Chiu, C., Daikos, G., Dhar, S., et al. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.05.046 · Cited by 1
Self-citationVithunes, S. M., Priyanka, S., Jose, J., Sajeev, N. T., Ranganathan, H., Gurusamy, V., Siram, K., & Sankar, V. (2018) · Drugs & Therapy Perspectives · doi:10.1007/s40267-018-0548-5 · Cited by 1
Kumari, S., Bagati, K. D., Sadasivam, B. K., & Babu, G. C. (2021) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_4_21 · Cited by 1
Vu, T. L. N., Dang, N. D. T., & Nguyen, T. T. T. (2022) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.4359 · Cited by 1
Zabidi, M. S., Bakar, R. A., Musa, N., Mustafa, S., Ismail, W. N. W., Manap, S. N. A. A., Zaid, N. A. C. M., & Yusuf, W. N. W. (2023) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2023.2262002 · Cited by 1
Sorlí, L., Luque, S., Li, J., Benítez-Cano, A., Fernández-Sala, X., Prim, N., Vega, V., Gómez‐Junyent, J., López-Montesinos, I., Gómez-Zorrilla, S., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02967-23 · Cited by 1
Self-citationLuque, S., Sorlí, L., Li, J., Fernández-Sala, X., Berenguer, N., Colominas-González, E., Benítez-Cano, A., Montero, M., Subirana, I., Prim, N., et al. (2024) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001216 · Cited by 1
Self-citationADVANCES AND CHALLENGES IN THE TREATMENT OF NEONATAL INFECTIONS: A NARRATIVE REVIEW
Teixeira, T. A., Destêfani, A. C., & Destefani, V. C. (2024) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v10i8.15341 · Cited by 1
Moradi, H., Sajadi-Javan, Z. S., Mousavi, S., Rostami, S., & Khaniabadi, B. M. (2024) · Iranian Journal of Microbiology · doi:10.18502/ijm.v16i6.17244 · Cited by 1
Plant, A. J., & Auckland, C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00351-18 · Cited by 1
Yu, X., Zhang, C., Pan, J., Dai, Y., Zhou, Z., Yang, F., Sun, R., Wang, Y., Cao, Y., Sheng, C., et al. (2020) · medRxiv · doi:10.1101/2020.01.24.20018481 · Cited by 1
Hua, X., Li, C., Pogue, J. M., Sharma, V., Karaiskos, I., Kaye, K. S., Tsuji, B. T., Bergen, P. J., Zhu, Y., Song, J., et al. (2020) · JMIR mhealth and uhealth · doi:10.2196/26593 · Cited by 1
Self-citationChe, E., & Patel, H. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky430 · Cited by 1
Halim, J., King, M. A., Nikolic, D., & Palacios, C. F. (2025) · Research Square · doi:10.21203/rs.3.rs-6727622/v1 · Cited by 1
Colistin Dosing in Continuous Renal Replacement Therapy
Honore, P. M., Malbrain, M. L. N. G., & Spapen, H. D. (2018) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-319-73670-9_6
Dosing of antibiotics in patients with sepsis, including those undergoing renal replacement therapy
Shalginskikh, A. O., Yakovlev, S. V., Николаевич, П. Д., Sychev, I. N., Петровна, С. М., & Bykov, A. O. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-1-16(391)-47-57
AMPK/mTOR Pathway Mediates Autophagy Activation in Colistin-Induced NephrotoxicityPreprint
Yang, T., Wang, X., Xiao, Y., Yan, K., Niu, H., Chen, H., Wang, J., & Cai, Y. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4007181
Antimicrobials in the Management of Sepsis
Jacobi, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88271-2.00032-8
Thử nghiệm phối hợp Colistin và Amikacin trên các chủng Klebsiella pneumoniae kháng Carbapenem
Quỳnh, N. V., & Nhung, P. H. (2023) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v163i2.1399
Population pharmacokinetics of intravenous colistin in pediatrics (poppicop study)
Wacharachaisurapol, N. (2020) · Chula Digiverse · doi:10.58837/chula.the.2020.119
Caracterización de la utilización de colistín en un hospital de alta complejidad
Cristóbal Monzón, T., Roberto Olivares, C., Fernanda Ávila, O., Matilde Lagos, P., & Mario Luppi, N. (2023) · Revista chilena de infectología · doi:10.4067/s0716-10182023000300203
Gajdács, M., Ábrók, M., Lázár, A., & Burián, K. (2020) · Magyar urológia · doi:10.22591/magyarurol.2020.3.berczics.97
Hydross, M. V., Samad, S. A., Savitri, M. B., & Upadhyay, A. D. (2024) · Motaleat-e Tatbiqi-e Honar · doi:10.61186/jommid.12.1.50
Enhanced Antibiotic Stewardship Program's Effect on Antibiotic Stewardship in Four Thai Hospitals
Jantarathaneewat, K., Thatrimontrichai, A., Pruetpongpun, N., Chansirikarnjana, S., Rutjanawech, S., Weber, D. J., & Apisarnthanarak, A. (2025) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2025.03.001
Guan, Y., Song, Z., Chen, Y., Feng, J., Fan, Y., & Rui, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1593674
Darnalis, N. M., Zainal, H., & Germovsek, E. (2025) · Journal of Scientometric Research · doi:10.5530/jscires.20250983
Effect of Renal Filtration Function on Polymyxin B Pharmacokinetics in Patients with Sepsis
Alimov, A. I., Galvidis, I. A., Surovoy, Y. A., Gutnikov, A. I., Tsarenko, S. V., & Burkin, M. A. (2025) · General Reanimatology · doi:10.15360/1813-9779-2025-6-13-21
Pan, Q., Gao, J. L., Kang, S., Zhao, J., Yu, J., & Pan, W. (2025) · Research Square · doi:10.21203/rs.3.rs-8146107/v1
Kim, D.-H., Kwack, W. G., Kwon, M., Shin, E. H., Kim, K.-Y., & Kim, B. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s563578
Згржебловська, Л. В., Malysh, I. R., & Berezenko, I. M. (2026) · Infusion & Chemotherapy · doi:10.32902/2663-0338-9-2026-1-11-16
Pharmacocinétique et suivi thérapeutique pharmacologique de la colistine
Magréault, S. (2019) · theses.fr (ABES) · doi:10.70675/60f726bez796bz4ffdzab04zf0142a2d75db
Mechanisms and PK/PD modelling of MCR-1-induced adaptive resistance in Enterobacteriaceae
Hariyanto, I. H. (2020) · theses.fr (ABES) · doi:10.70675/774a06e3zbe58z42f4zae8fzed30da843945
Zhang, S., Ling, J., Xu, Y., Yang, X., Zuo, L., Wang, L., Deng, Y., Hu, N., & Chen, R. (2026) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/jcpt/1196496
Colistin Use in Critically Ill Burn Patients: Issues of Augmented Renal Clearance and Nephrotoxicity
Hải, L. B., Anh, L. Q., Anh, L. N., Minh, V. D. A., Ha, L. M., Trang, L. T. T., Hanh, H. M., Thắm, N. T., Van, P. T. T., & Hải, N. T. (2026) · VNU Journal of Science Medical and Pharmaceutical Sciences · doi:10.25073/2588-1132/vnumps.4983
Surovoy, Y. A., Galvidis, I. A., Alimov, A. I., Wang, Z. P., Melekhin, A. O., & Burkin, M. A. (2026) · Pharmaceuticals · doi:10.3390/ph19060880
Fu, J., Ling, R., Jie, F., Chen, Y., Gong, W., Kong, M., Qin, S., Chen, Y., Chen, Y., Zhang, C., et al. (2026) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2026.06.003
Xu, A., Xiong, X., Zhang, N., Qu, G., Zhang, Z., & Cai, Y. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107884
Rajan, A. K., Onofrei, M. I., Rudra, A., Paul, S., Shanbhag, V., Madi, M. D., Mahabala, C., Kunhikatta, V., Prabhu, R., Mallayasamy, S., et al. (2026) · Postgraduate Medicine · doi:10.1080/00325481.2026.2692127
Tao, C., & Hu, Q. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1885309
Zhu, Q., Wang, J., Li, F., Shen, J., Gong, X., Yang, B., Xia, X., & Tu, Y. (2026) · Medicine · doi:10.1097/md.0000000000050278
Comparative Neurotoxicity of Polymyxin B and Colistin in Patients With Cancer
Aitken, S. L., Aboujaoude, E., Borjan, J., & Tverdek, F. P. (2026) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.70202
Bastias, N. M. A. (2023) · Repositorio Institucional Académico , Sistema de Bibliotecas Universidad Andrés Bello (UNAB) (Universidad Andrés Bello (UNAB))
KEBIJAKAN IMPLEMENTASI PROGRAM ANTIMICROBIAL STEWARDSHIP
Pratama, M. F. A., & Darmawan, E. S. (2023) · Jurnal Cahaya Mandalika
Barriers to appropriate antimicrobial dosing in the intensive care unit
Das, S. K. (2026) · Onco Critical Care. · doi:10.18231/j.occ.14088.1791188917
Дозирование антибиотиков у пациентов с сепсисом, которым проводится заместительная почечная терапия
О., Ш. А., Yakovlev, S. V., Н., П. Д., Н., С. И., П., С. М., & О., Б. А. (n.d.) · CyberLeninK (CyberLeninka)
Lee, S., Jun, C.-H., Kim, H. T., Cho, H. K., Jung, J. W., Kim, S., & Wi, Y. M. (2026) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2026.103410
Bhandari, R. K., Sidana, T., Murali, N., Pandey, A. K., Vij, S., Malhotra, S., Duseja, A. K., Taneja, S., Singla, V., Sharma, S., et al. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2757684
Multi-Objective Optimization of Population-Level Dosing Regimens
Tandar, S. T., Beldjenna, M., Nicholl-Morris, K., van Wijk, R. C., Guo, T., Aulin, L. B. S., & van Hasselt, J. G. C. (2026) · Clinical Pharmacokinetics · doi:10.1007/s40262-026-01714-5
Yuan, J., Carmeli, Y., Cisneros, J. M., Daikos, G. L., Paul, M., Zhao, Y., 许进福, Ma, Y., Xu, W., Wible, M., et al. (2026) · Infectious Diseases and Therapy · doi:10.1007/s40121-026-01477-3
Metadata
- Authors
- Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P.
- Affiliations
- Monash University (AU)
- School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo 3 ;
- Siriraj Hospital (TH)
- Fourth Department of Internal Medicine, University of Athens 6 Medical School ,
- University at Buffalo, State University of New York (US)
- The University of Queensland (AU)
- University of Pittsburgh Medical Center (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-23
- Volume
- 64
- Issue
- 5
- Pages
- 565-571
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5850520
- OpenAlex
- W2566638444
- Cited by
- 262
- References
- 27
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 18 · 2023: 17 · 2022: 31 · 2021: 27 · 2020: 42 · 2019: 42 · 2018: 27 · 2017: 23
- FWCI
- 24.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI070896)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- colistin, intravenous administration, dosing algorithm, critically ill patients, nephrotoxicity, population pharmacokinetics, creatinine clearance, renal replacement therapy, colistimethate, steady-state plasma concentration, antibiotic dosing
- MeSH terms
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Colistin, Female, Humans, Male, Middle Aged, Pilot Projects, Critical Illness, Practice Guidelines as Topic, Renal Replacement Therapy, Young Adult, Administration, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.